Clinical Trial Update: Determination In-vivo KUF for Diacap Pro Hemodialyser [NA]

View source ↗

Summary

This update reports the completion of a clinical trial evaluating the in-vivo ultrafiltration performance (KUF) of the Diacap Pro Hemodialyser.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• Diacap Pro Hemodialyser

Snippet

Sponsor: B.Braun Avitum AG | Conditions: Kidney Failure,Chronic, Renal Insufficiency,Chronic | NA | Status: COMPLETED